DIFICID®

Drug Information Related Patent

Hold Company

MERCK SHARP DOHME

Learn More

Dosage and Administration

TABLET;ORAL

Specification

200MG

Indication

DIFICID® is indicated for the treatment of Clostridium Difficile-associated Diarrhea (CDAD) in adults.

Use

Instructions for Use

API

FIDAXOMICIN

API Structure

We Supply

FIDAXOMICIN

Note:

USP/EP/CP
Facility GMP
DMF/CDE

null

Note:

null

Note:

null

Drug Patent

Patent No	Expiration Date
7378508	2027/7/31
7378508*PED	2028/1/31
7863249	2027/7/31
7863249*PED	2028/1/31
7906489	2027/3/4
7906489*PED	2027/9/4
8586551*PED	2024/1/15
8859510	2027/7/31
8859510*PED	2028/1/31

API Patent

Patent No	Expiration Date
7378508	2027/7/31
7378508*PED	2028/1/31
7863249	2027/7/31
7863249*PED	2028/1/31
8859510	2027/7/31
8859510*PED	2028/1/31

Note: The patent information provided herein is derived solely from publicly available data in the FDA Orange Book (or other cited sources) and is presented for general informational purposes only. Actual patent status may vary based on jurisdictional rulings, regulatory extensions or other factors.

HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

INFORMATION

Tel:
E-mail:
Address:
WhatsAPP

Member of

CERTIFICATION